Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) Invested Capital (2016 - 2025)

Historic Invested Capital for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $6.7 billion.

  • Resmed's Invested Capital rose 1367.4% to $6.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.7 billion, marking a year-over-year increase of 1367.4%. This contributed to the annual value of $6.6 billion for FY2025, which is 1914.81% up from last year.
  • Per Resmed's latest filing, its Invested Capital stood at $6.7 billion for Q4 2025, which was up 1367.4% from $6.5 billion recorded in Q3 2025.
  • Resmed's Invested Capital's 5-year high stood at $6.7 billion during Q4 2025, with a 5-year trough of $3.4 billion in Q1 2021.
  • In the last 5 years, Resmed's Invested Capital had a median value of $5.6 billion in 2023 and averaged $5.2 billion.
  • Per our database at Business Quant, Resmed's Invested Capital crashed by 535.65% in 2021 and then skyrocketed by 4489.14% in 2022.
  • Resmed's Invested Capital (Quarter) stood at $3.8 billion in 2021, then surged by 44.89% to $5.5 billion in 2022, then grew by 3.07% to $5.7 billion in 2023, then grew by 3.81% to $5.9 billion in 2024, then grew by 13.67% to $6.7 billion in 2025.
  • Its last three reported values are $6.7 billion in Q4 2025, $6.5 billion for Q3 2025, and $6.6 billion during Q2 2025.